Distinct requirements for IFNs and STAT1 in NK cell function

Journal of Immunology

Volumn 165, Issue 7, 2000, Pages 3571-3577

  Lee, C K ^a   Rao, D T ^a   Gertner, R ^a   Gimeno, R ^a   Frey, A B ^a   Levy, D E ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON RECEPTOR; ALPHA1 INTERFERON; ALPHA2 INTERFERON; GAMMA INTERFERON; GRANZYME A; GRANZYME B; INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; PERFORIN; SERINE PROTEINASE; STAT1 PROTEIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLYSIS; EFFECTOR CELL; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE FUNCTION; MOUSE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL;

EID: 0034292328     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.7.3571     Document Type: Article

References (51)

1. Biology of natural killer cells
2. The enigma of the natural killer cell
3. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
4. Interferon: A major regulator of natural killer cell-mediated cytotoxicity
5. Antiviral activity induced by culturing lymphocytes with tumor-derived or virus transformed cells. Enhancement of human natural killer cell activity interferon and antagonistic inhibition of susceptibility of target cells to lysis
6. Role of early cytokines, including α and β interferons (IFN-α/β), in innate and adaptive immune responses to viral infections
7. Multiple defects of immune cell function in mice with disrupted interferon-γ genes
8. Natural killer cell differentiation: Insights from knockout and transgenic mouse models and in vitro systems
9. + T cells
10. Interleukin 2 receptor signaling regulates the perform gene through signal transducer and activator of transcription (Stat)5 activation of two enhancers
11. Modulation of perforin and granzyme messenger RNA expression in human natural killer cells
12. The interleukin-12/interleukin-12-receptor system: Role in normal and pathologic immune responses
13. Enhancing effect of natural killer cell stimulatory factor (NKSF/IL-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells
14. IL-12-deficient mice are defective in IFNγ production and type 1 cytokine responses
15. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice
16. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells
17. Defective NK cell activity and Th1 response in IL-18-deficient mice
18. Type I interferon modulates innate and specific anti-viral immunity
19. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens
20. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation
21. Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptorβ chain
22. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor 7 chain
23. Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity
24. Defective lymphoid development in mice lacking Jak3
25. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells
26. Transcriptional responses to polypeptide ligands: The Jak-Stat pathway
27. Complementation of a mutant cell line: Central role of the 91 kDa polypeptide of ISGF3 in the interferon-α and -γ signal transduction pathways
28. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease
29. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway
30. Differential regulation of constitutive major histocompatibility complex class I expression in T and B lymphocytes
31. STAT1 affects lymphocyte survival and proliferation partially independent of its role downstream of IFN-γ
32. Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
33. Differentiation of antitumor CTL in vivo requires host expression of Stat1
34. A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons α and β and alters macrophage responses
35. Mice lacking the IFN-γ receptor have an impaired ability to resolve a lung eosinophilic inflammatory response associated with a prolonged capacity of T cells to exhibit a Th2 cytokine profile
36. YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage
37. Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter
38. A signal transducer and activator of transcription (Stat)4-independent pathway for the development of T helper type I cells
39. Tumor cell responses to IFNγ affect tumorigenicity and response to IL-12 therapy and antiangiogenesis
40. CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-γ
41. Association of DAP12 with activating CD94/NKG2C NK cell receptors
42. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells
43. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
44. FGF signaling inhibits chondrocyte proliferatin and regulates bone development through the Stat1 pathway
45. Impairment of natural killer cytotoxic activity and interferon gamma production in CCAAT/enhancer binding protein gamma-deficient mice
46. Interleukin-18 binding protein: A novel modulator of the Th1 cytokine response
47. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-gamma production
48. Activation of interferon-γ inducing factor mediated by interleukin-1β converting enzyme
49. Interleukin-18 regulation of interferon γ production and cell proliferation as shown in interleukin-1β-converting enzyme (caspase- 1)-deficient mice
50. + memory T cells by opposing cytokines
51. Host MHC class I gene control of NK-cell specificity in the mouse